7-101172092-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_198571.3(NAT16):c.1097A>G(p.Glu366Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000882 in 1,610,778 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_198571.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NAT16 | NM_198571.3 | c.1097A>G | p.Glu366Gly | missense_variant | Exon 4 of 4 | ENST00000300303.7 | NP_940973.2 | |
NAT16 | NM_001369694.1 | c.1097A>G | p.Glu366Gly | missense_variant | Exon 5 of 5 | NP_001356623.1 | ||
NAT16 | NM_001369695.1 | c.1097A>G | p.Glu366Gly | missense_variant | Exon 4 of 4 | NP_001356624.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NAT16 | ENST00000300303.7 | c.1097A>G | p.Glu366Gly | missense_variant | Exon 4 of 4 | 2 | NM_198571.3 | ENSP00000300303.2 | ||
NAT16 | ENST00000455377.5 | c.1097A>G | p.Glu366Gly | missense_variant | Exon 5 of 5 | 1 | ENSP00000395125.1 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152120Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000190 AC: 47AN: 247522Hom.: 1 AF XY: 0.000171 AC XY: 23AN XY: 134346
GnomAD4 exome AF: 0.0000857 AC: 125AN: 1458658Hom.: 1 Cov.: 32 AF XY: 0.0000923 AC XY: 67AN XY: 725584
GnomAD4 genome AF: 0.000112 AC: 17AN: 152120Hom.: 0 Cov.: 32 AF XY: 0.000135 AC XY: 10AN XY: 74308
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1097A>G (p.E366G) alteration is located in exon 4 (coding exon 3) of the NAT16 gene. This alteration results from a A to G substitution at nucleotide position 1097, causing the glutamic acid (E) at amino acid position 366 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at